What Is The Current and Historic Market Size Analysis Of The Multiplex PCR Assays Market?
The multiplex pcr assays market has seen considerable growth due to a variety of factors.
• The multiplex PCR assays market has seen rapid growth. It is projected to rise from $1.51 billion in 2024 to $1.72 billion in 2025, with a CAGR of 13.6%.
This growth is due to the increasing prevalence of infectious diseases, greater government funding, increased adoption in clinical diagnostics, the rise of genetic testing, and advancements in bioinformatics.
What Is The Forecast For The Multiplex PCR Assays Market Size?
The multiplex pcr assays market is expected to maintain its strong growth trajectory in upcoming years.
• The multiplex PCR assays market is forecast to reach $2.83 billion by 2029, growing at a CAGR of 13.4%.
The growth is driven by expanding application areas, demand for point-of-care diagnostics, personalized medicine, increased R&D expenditures, and rising health awareness. Key trends include NGS integration, digital PCR, automation, point-of-care devices, AI and machine learning, and cloud solutions.
What Are The Essential Drivers Behind The Growth Of The Multiplex PCR Assays Market?
The increasing demand for diagnostic testing is expected to propel the multiplex PCR assay market. As chronic diseases like cancer and diabetes increase, early and accurate diagnostic testing is critical for management. Multiplex PCR assays enhance diagnostic testing by detecting multiple pathogens or genetic markers simultaneously. In 2024, NHS data showed a 21% rise in diagnostic tests compared to the previous year.
How Is The Global Multiplex PCR Assays Market Divided Into Key Segments?
The multiplex pcr assays market covered in this report is segmented –
1) By Assay Type: Planar Assay, Bead Based Assay
2) By Product And Services: Consumables, Instruments, Software And Services
3) By Application: Disease Diagnosis, Research And Development, Other Applications
4) By End User: Biopharmaceutical Companies, Clinical Research Organizations, Academic Research Institutes, Diagnostic Centers, Other End Users
Subsegments:
1) By Planar Assay: Microarray-Based Assays, Dna Chip-Based Assays
2) By Bead Based Assay: Luminex Xmap Assays, Magpix Assays, Flow Cytometry-Based Bead Assays
Pre-Book The Multiplex PCR Assays Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Multiplex PCR Assays Market?
Key players in the multiplex PCR assays market are prioritizing the incorporation of automation, for example, next-generation quantitative PCR (qPCR) systems, to offer exact and versatile nucleic acid quantification for refined clinical diagnostics and public health. These next-generation qPCR systems deliver high-throughput, precise, and collective detection of numerous targets, boosting diagnostic precision and efficacy. An illustration of this came in November 2023 when Roche Diagnostics Corporation, a company based in Switzerland that manufactures diagnostic system solutions, introduced the LightCycler PRO System. This state-of-the-art qPCR platform has the capacity for high-throughput, accurate, and concurrent detection of various targets. With improved temperature uniformity, innovative software, and compatibility with over 200 LightMix Modular and 60 CE-IVD assays, it enhances diagnostic precision and efficacy. This system represents the merging of automation in the Multiplex PCR Assays market, propelling clinical diagnostics and public health forward.
Who Are the Key Players In The Multiplex PCR Assays Market?
Major companies operating in the multiplex PCR assays market are:
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Inc
• Abbott Laboratories
• Danaher Corporation
• Merck KGaA
• Siemens Healthineers
• Becton Dickinson and Company
• Agilent Technologies Inc
• PerkinElmer Inc
• Illumina Inc
• Sysmex Corporation
• Bio-Rad Laboratories Inc
• QIAGEN NV
• Tecan Group Ltd
• DiaSorin SpA
• Bio-Techne Corporation
• Promega Corporation
• Randox Laboratories Ltd
• BioFire Diagnostics Inc
• Seegene Inc
• Quanterix Corporation
• NanoString Technologies
• Standard BioTools Inc
• Enzo Biochem Inc
• SeraCare Life Sciences Inc
• Agena Bioscience
• Fluidigm Corporation
What Are The Regional Insights Into The Multiplex PCR Assays Market?
North America was the largest region in the multiplex PCR assays market in 2024. The regions covered in the multiplex PCR assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
